Astec LifeSciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences Limited has submitted to the stock exchange a statement of deviation(s) or variation(s) under Regulation 32 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. This filing is a mandatory compliance disclosure that relates to any deviation from the previously disclosed objects or use of proceeds from a past fund-raising activity such as a public, rights, or preferential issue. No further details regarding the nature or quantum of deviation have been provided in the headline.
This is a routine regulatory compliance filing rather than a strategic announcement. Investors should look for the detailed deviation statement to understand whether any funds raised earlier have been reallocated or used differently from the originally stated purpose, which could affect governance confidence.